Biomarker Predicts Severe Hypertension With Bevacizumab Biomarker Predicts Severe Hypertension With Bevacizumab

A new biomarker may identify the 40% of patients with cancer who develop potentially life-threatening severe hypertension when treated with bevacizumab.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news